Pharmafocus Home
    
Keyword Search
Go News Archive Features Events Appointments Jobs Contact Us About Us
Latest Features ( May )
Should I stay or should I go?
There are no easy answers when it comes to timing a job move, says Tim Ewbank, but you can make yourself a more attractive candidate for that next job.(more)
Regional research still hampered by cross-border differences
In the age of the Euro-trial, patients are not well served by processes that add unnecessary delays to the development of new medicines, says Les Rose(more)
A sea of paperwork or business as usual?
Steven Gray looks ahead to the soon-to-be finalised 2008 ABPI Code of Practice and how it will affect everyday practice in the UK industry(more)
Pharmafocus.comNews Headlines Register for News Alert
News for December 2006
Previous Months: April 2008 |  March 2008 |  February 2008 |  January 2008 |  December 2007 |  November 2007 |  October 2007 |  September 2007 |  August 2007 |  July 2007 |  June 2007 |  May 2007 |  April 2007 |  March 2007 |  February 2007 |  January 2007 |  December 2006 |  November 2006 |  October 2006 |  September 2006 |  August 2006 |  July 2006 |  June 2006 |  May 2006 |  April 2006 |  March 2006 |  February 2006 |  January 2006 |  December 2005 |  November 2005 |  October 2005 |  September 2005 |  August 2005 |  July 2005 |  June 2005 |  May 2005 |  April 2005 |  March 2005 |  February 2005 |  January 2005 |  December 2004 |  November 2004 |  October 2004 |  September 2004 |  August 2004 |  July 2004 |  June 2004 |  May 2004 |  April 2004 |  March 2004 |  February 2004 |  January 2004 |  December 2003 |  November 2003 |  October 2003 |  September 2003 |  August 2003 |  July 2003 |  June 2003 |  May 2003 |  April 2003 |  March 2003 |  February 2003 |  January 2003 |  December 2002 |  November 2002 | 

  What is RSS?

GSK's mock vaccine gets EU positive opinion
Company aims to be ready for action in event of avian flu pandemic..(more)

 Protherics raises £38m to expand development pipeline
Three-pronged move strengthens company's presence in critical care and cancer ..(more)

 Birmingham hospital merger to be first of many
Mergers seen as way to stabilise finances of debt-ridden hospitals..(more)

 Merck outlines turnaround strategy
Reorganisation aims to achieve cost-savings across the whole company..(more)

 Confidence in UK medicine safety high
But low awareness of the role of the MHRA among both the public and doctors..(more)

 Tycerb in landmark cancer trial
GSK's drug could be potential rival to Roche's Herceptin..(more)

 Government unveils plans for improved patient involvement
LINks scheme aims to boost patient power..(more)

 GSK buys antibody firm Domantis for £230 million
But it could take some time for company to reap its rewards..(more)

 National cancer network underpins prostate vaccine trial
Onyvax and NCRN join forces in first collaboration of its type..(more)

 Chance missed to reform NHS finance controls, say managers
Disappointment as DH confirms RAB system will continue ..(more)

 Novartis readies Prexige for European launch
Drug overcomes close scrutiny of safety data..(more)

 New UK body to fast-track breakthrough research
Chancellor confirms budget of £1 billion for R&D..(more)

 TroVax a step nearer to orphan status
Vaccine in trials as combination treatment for renal and breast cancer..(more)

 Closer scrutiny for high-risk clinical trials
Final report into Northwick Park heralds changes..(more)

 UK uptake of new medicines 'about right' say doctors
Britain's prescribing habits lag behind other EU countries ..(more)

 New treatment for patients resistant to cancer drug Glivec
BMS' Sprycel seen as first major advance in CML treatment in five years..(more)

 Smoking cessation drug launched
Pfizer achieves perfect timing as it takes advantage of public smoking ban..(more)

 PAN Advertising sold to marketing services group Creston
Sale represents further example of globalisation of healthcare communications..(more)

 Galen launches new COPD cough treatment
Erdotin offers improved treatment but without increased costs ..(more)

 Cholesterol drug failure hits Pfizer
Torcetrapib cancellation leaves large hole in company's future revenues..(more)

 Bayer beats predictions in third quarter results
Acquisition of Schering boosts business by 80 million euros..(more)

 Byetta receives EU approval for Type II diabetes
But new drugs from Merck and Novartis could have a damaging effect on future sales..(more)

 New blindness treatment moves closer to market
Novartis' Lucentis over first hurdle on road to EU approval..(more)

 Takeover will create UK leader in pulmonary products
Vectura buys Innovata for £131m after massive fundraising effort..(more)

 Merck to diversify its DTC marketing
Less TV and more internet advertising could be money well spent..(more)

 AZ sales hit by launch of generic Toprol
Company responds by signing agreement to produce second generic..(more)

 Link Holdings bought by niche pharma company Archimedes
Acquisition provides important additions to Archimedes' specialist portfolio..(more)

 Work to begin on Cancer Reform Strategy for NHS
But government stops short of advising on spending commitments..(more)

 Pfizer cuts 2,200 US sales reps
Biggest ever salesforce reduction seen as a sign of the times..(more)

 Kindler sets out new vision for Pfizer
New chief executive wastes no time in making fundamental changes..(more)

 England set for smoking ban from July
Increase in sales of OTC and prescription smoking-cessation products expected..(more)

Are you a Pharmafocus subscriber?

Subscribe Now 

Visit our sister sites: 

InPharm.com 

Pharmafile.com 

Pharmafocus.com © 2006 Pharmafile Ltd.